Tacalcitol

Drug Profile

Tacalcitol

Alternative Names: Bonalfa; Curatoderm; Psoraderm; Psoravit; TV 02; TV-02H

Latest Information Update: 23 Jun 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Teijin Pharma
  • Developer Profex; Teijin Pharma
  • Class Anti-inflammatories; Antiallergics; Antipruritics; Antipsoriatics; Dihydroxycholecalciferols; Small molecules
  • Mechanism of Action Vitamin D3 stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Plaque psoriasis; Psoriasis

Most Recent Events

  • 17 Apr 2015 No recent reports on development identified - Preregistration for Plaque psoriasis in China (Topical)
  • 20 Sep 2010 Preregistration for Plaque psoriasis (20 µg/g dose) in China (Topical ointment)
  • 27 Jun 2006 Launched for Plaque psoriasis (20 µg/g dose) in Japan (Topical lotion)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top